Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Neurology
Published in: BMC Neurology 1/2011

Open Access 01-12-2011 | Research article

Decreased brain venous vasculature visibility on susceptibility-weighted imaging venography in patients with multiple sclerosis is related to chronic cerebrospinal venous insufficiency

Authors: Robert Zivadinov, Guy U Poloni, Karen Marr, Claudiu V Schirda, Christopher R Magnano, Ellen Carl, Niels Bergsland, David Hojnacki, Cheryl Kennedy, Clive B Beggs, Michael G Dwyer, Bianca Weinstock-Guttman

Published in: BMC Neurology | Issue 1/2011

Login to get access

Abstract

Background

The potential pathogenesis between the presence and severity of chronic cerebrospinal venous insufficiency (CCSVI) and its relation to clinical and imaging outcomes in brain parenchyma of multiple sclerosis (MS) patients has not yet been elucidated. The aim of the study was to investigate the relationship between CCSVI, and altered brain parenchyma venous vasculature visibility (VVV) on susceptibility-weighted imaging (SWI) in patients with MS and in sex- and age-matched healthy controls (HC).

Methods

59 MS patients, 41 relapsing-remitting and 18 secondary-progressive, and 33 HC were imaged on a 3T GE scanner using pre- and post-contrast SWI venography. The presence and severity of CCSVI was determined using extra-cranial and trans-cranial Doppler criteria. Apparent total venous volume (ATVV), venous intracranial fraction (VIF) and average distance-from-vein (DFV) were calculated for various vein mean diameter categories: < .3 mm, .3-.6 mm, .6-.9 mm and > .9 mm.

Results

CCSVI criteria were fulfilled in 79.7% of MS patients and 18.2% of HC (p < .0001). Patients with MS showed decreased overall ATVV, ATVV of veins with a diameter < .3 mm, and increased DFV compared to HC (all p < .0001). Subjects diagnosed with CCSVI had significantly increased DFV (p < .0001), decreased overall ATVV and ATVV of veins with a diameter < .3 mm (p < .003) compared to subjects without CCSVI. The severity of CCSVI was significantly related to decreased VVV in MS (p < .0001) on pre- and post-contrast SWI, but not in HC.

Conclusions

MS patients with higher number of venous stenoses, indicative of CCSVI severity, showed significantly decreased venous vasculature in the brain parenchyma. The pathogenesis of these findings has to be further investigated, but they suggest that reduced metabolism and morphological changes of venous vasculature may be taking place in patients with MS.
Appendix
Available only for authorised users
Literature
1.
Lassmann H, Bruck W, Lucchinetti CF: The immunopathology of multiple sclerosis: an overview. Brain Pathol. 2007, 17 (2): 210-218. 10.1111/j.1750-3639.2007.00064.x.CrossRefPubMed
2.
Ge Y, Law M, Herbert J, Grossman RI: Prominent perivenular spaces in multiple sclerosis as a sign of perivascular inflammation in primary demyelination. AJNR Am J Neuroradiol. 2005, 26 (9): 2316-2319.PubMed
3.
Adams C: Perivascular iron deposition and other vascular damage in multiple sclerosis. J Neurol Neurosurg Psychiatry. 1988, 51: 260-265. 10.1136/jnnp.51.2.260.CrossRefPubMedPubMedCentral
4.
Tan IL, van Schijndel RA, Pouwels PJ, van Walderveen MA, Reichenbach JR, Manoliu RA, Barkhof F: MR venography of multiple sclerosis. AJNR Am J Neuroradiol. 2000, 21 (6): 1039-1042.PubMed
5.
Ge Y, Zohrabian VM, Grossman RI: Seven-Tesla magnetic resonance imaging: new vision of microvascular abnormalities in multiple sclerosis. Arch Neurol. 2008, 65 (6): 812-816. 10.1001/archneur.65.6.812.CrossRefPubMedPubMedCentral
6.
Hammond KE, Metcalf M, Carvajal L, Okuda DT, Srinivasan R, Vigneron D, Nelson SJ, Pelletier D: Quantitative in vivo magnetic resonance imaging of multiple sclerosis at 7 Tesla with sensitivity to iron. Ann Neurol. 2008, 64 (6): 707-713. 10.1002/ana.21582.CrossRefPubMed
7.
Tallantyre EC, Brookes MJ, Dixon JE, Morgan PS, Evangelou N, Morris PG: Demonstrating the perivascular distribution of MS lesions in vivo with 7-Tesla MRI. Neurology. 2008, 70 (22): 2076-2078. 10.1212/01.wnl.0000313377.49555.2e.CrossRefPubMed
8.
Tallantyre EC, Morgan PS, Dixon JE, Al-Radaideh A, Brookes MJ, Evangelou N, Morris PG: A comparison of 3T and 7T in the detection of small parenchymal veins within MS lesions. Invest Radiol. 2009, 44 (9): 491-494. 10.1097/RLI.0b013e3181b4c144.CrossRefPubMed
9.
Reichenbach JR, Venkatesan R, Schillinger DJ, Kido DK, Haacke EM: Small vessels in the human brain: MR venography with deoxyhemoglobin as an intrinsic contrast agent. Radiology. 1997, 204 (1): 272-277.CrossRefPubMed
10.
Ge Y, Zohrabian VM, Osa EO, Xu J, Jaggi H, Herbert J, Haacke EM, Grossman RI: Diminished visibility of cerebral venous vasculature in multiple sclerosis by susceptibility-weighted imaging at 3.0 Tesla. J Magn Reson Imaging. 2009, 29 (5): 1190-1194. 10.1002/jmri.21758.CrossRefPubMedPubMedCentral
11.
Putnam T, Adler A: Vascular architecture of the lesions of mutliple scelrosis. Arch Neurol Psychiatry. 1937, 38: 1-15.CrossRef
12.
Schelling F: Damaging venous reflux into the skull or spine: relevance to multiple sclerosis. Med Hypotheses. 1986, 21: 141-148. 10.1016/0306-9877(86)90003-4.CrossRefPubMed
13.
Putnam T: The pathogenesis of multiple sclerosis, a possible vascular factor. N Engl J Med. 1933, 209: 786-790. 10.1056/NEJM193310192091604.CrossRef
14.
Zamboni P, Galeotti R, Menegatti E, Malagoni AM, Tacconi G, Dall'ara S, Bartolomei I, Salvi F: Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry. 2009, 80 (4): 392-399.CrossRefPubMed
15.
Zamboni P, Menegatti E, Galeotti R, Malagoni AM, Tacconi G, Dall'Ara S, Bartolomei I, Salvi F: The value of cerebral Doppler venous haemodynamics in the assessment of multiple sclerosis. J Neurol Sci. 2009, 282 (1-2): 21-27. 10.1016/j.jns.2008.11.027.CrossRefPubMed
16.
Zamboni P, Galeotti R, Menegatti E, Malagoni AM, Gianesini S, Bartolomei I, Mascoli F, Salvi F: A prospective open-label study of endovascular treatment of chronic cerebrospinal venous insufficiency. J Vasc Surg. 2009, 50 (6): 1348-1358. 10.1016/j.jvs.2009.07.096. e1341-1343CrossRefPubMed
17.
Zamboni P, Menegatti E, Weinstock-Guttman B, Dwyer MG, Schirda CV, Malagoni AM, Hojnacki D, Kennedy C, Carl E, Bergsland N, Magnano C, Bartolomei I, Salvi F, Zivadinov R: Hypoperfusion of brain parenchyma is associated with the severity of chronic cerebrospinal venous insufficiency in patients with multiple sclerosis: a cross-sectional preliminary report. BMC Med. 2011, 9: 22-10.1186/1741-7015-9-22.CrossRefPubMedPubMedCentral
18.
Zamboni P, Menegatti E, Weinstock-Guttman B, Schirda C, Cox JL, Malagoni AM, Hojanacki D, Kennedy C, Carl E, Dwyer MG, Bergsland N, Galeotti R, Hussein S, Bartolomei I, Salvi F, Zivadinov R: The severity of chronic cerebrospinal venous insufficiency in patients with multiple sclerosis is related to altered cerebrospinal fluid dynamics. Funct Neurol. 2009, 24 (3): 133-138.PubMed
19.
Zivadinov R, Marr K, Cutter G, Ramanathan M, Benedict RH, Kennedy C, Elfadil M, Yeh AE, Reuther J, Brooks C, Hunt K, Andrews M, Carl E, Dwyer MG, Hojnacki D, Weinstock-Guttman B: Prevalence, sensitivity, and specificity of chronic cerebrospinal venous insufficiency in MS. Neurology. 2011, 77 (2): 138-144. 10.1212/WNL.0b013e318212a901.CrossRefPubMed
20.
Lublin FD, Reingold SC: Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology. 1996, 46 (4): 907-911.CrossRefPubMed
21.
Kurtzke JF: Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983, 33 (11): 1444-1452.CrossRefPubMed
22.
Hammond KE, Lupo JM, Xu D, Metcalf M, Kelley DA, Pelletier D, Chang SM, Mukherjee P, Vigneron DB, Nelson SJ: Development of a robust method for generating 7.0 T multichannel phase images of the brain with application to normal volunteers and patients with neurological diseases. Neuroimage. 2008, 39 (4): 1682-1692. 10.1016/j.neuroimage.2007.10.037.CrossRefPubMed
23.
Zivadinov R, Heininen-Brown M, Schirda C, Bergsland N, Magnano C, Durfee J, Kennedy C, Carl E, Hagemeier J, Benedict R, Weinstock-Guttman B, Dwyer MG: Abnormal subcortical deep-gray matter susceptibility-weighted imaging filtered phase measurements in patients with multiple sclerosis. A case-control study. Neuroimage. 2012, 59 (1): 331-339. 10.1016/j.neuroimage.2011.07.045.CrossRefPubMed
24.
Sled JG, Zijdenbos AP, Evans AC: A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans Med Imaging. 1998, 17 (1): 87-97. 10.1109/42.668698.CrossRefPubMed
25.
Haacke EM, Xu Y, Cheng YC, Reichenbach JR: Susceptibility weighted imaging (SWI). Magn Reson Med. 2004, 52 (3): 612-618. 10.1002/mrm.20198.CrossRefPubMed
26.
Sato Y, Nakajima S, Shiraga N, Atsumi H, Yoshida S, Koller T, Gerig G, Kikinis R: Three-dimensional multi-scale line filter for segmentation and visualization of curvilinear structures in medical images. Med Image Anal. 1998, 2 (2): 143-168. 10.1016/S1361-8415(98)80009-1.CrossRefPubMed
27.
Smith SM, Zhang Y, Jenkinson M, Chen J, Matthews PM, Federico A, De Stefano N: Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. Neuroimage. 2002, 17 (1): 479-489. 10.1006/nimg.2002.1040.CrossRefPubMed
28.
Barth M, Nobauer-Huhmann IM, Reichenbach JR, Mlynarik V, Schoggl A, Matula C, Trattnig S: High-resolution three-dimensional contrast-enhanced blood oxygenation level-dependent magnetic resonance venography of brain tumors at 3 Tesla: first clinical experience and comparison with 1.5 Tesla. Invest Radiol. 2003, 38 (7): 409-414.PubMed
29.
Lin W, Mukherjee P, An H, Yu Y, Wang Y, Vo K, Lee B, Kido D, Haacke EM: Improving high-resolution MR bold venographic imaging using a T1 reducing contrast agent. J Magn Reson Imaging. 1999, 10 (2): 118-123. 10.1002/(SICI)1522-2586(199908)10:2<118::AID-JMRI2>3.0.CO;2-V.CrossRefPubMedPubMedCentral
30.
Schirda C, Magnano C, Nayyar N, Cox J, Dwyer M, R Z: Contrast enhanced susceptibility weighted imaging (SWI) increases detection of iron deposition in patients with multiple sclerosis. A pilot study. Neurology. 2009, 72 (Suppl 3): P03.065-A139
31.
Zivadinov R, Rudick RA, De Masi R, Nasuelli D, Ukmar M, Pozzi-Mucelli RS, Grop A, Cazzato G, Zorzon M: Effects of IV methylprednisolone on brain atrophy in relapsing-remitting MS. Neurology. 2001, 57 (7): 1239-1247.CrossRefPubMed
32.
Yeh E, Weinstock-Guttman B, Ramanathan M, Ramasamy D, Willis L, Cox J, Zivadinov R: MRI characteristics of children and adults with pediatric-onset multiple sclerosis. Brain. 2009, 132 (12): 3392-3400. 10.1093/brain/awp278.CrossRefPubMed
33.
Ge Y, Jensen JH, Lu H, Helpern JA, Miles L, Inglese M, Babb JS, Herbert J, Grossman RI: Quantitative Assessment of Iron Accumulation in the Deep Gray Matter of Multiple Sclerosis by Magnetic Field Correlation Imaging. AJNR Am J Neuroradiol. 2007, 28 (9): 1639-1644. 10.3174/ajnr.A0646.CrossRefPubMed
34.
Haacke EM, Ayaz M, Khan A, Manova ES, Krishnamurthy B, Gollapalli L, Ciulla C, Kim I, Petersen F, Kirsch W: Establishing a baseline phase behavior in magnetic resonance imaging to determine normal vs. abnormal iron content in the brain. J Magn Reson Imaging. 2007, 26 (2): 256-264. 10.1002/jmri.22987.CrossRefPubMed
35.
D'Haeseleer M, Cambron M, Vanopdenbosch L, De Keyser J: Vascular aspects of multiple sclerosis. Lancet Neurol. 2011, 10 (7): 657-666. 10.1016/S1474-4422(11)70105-3.CrossRefPubMed
36.
Trapp BD, Stys PK: Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis. Lancet Neurol. 2009, 8 (3): 280-291. 10.1016/S1474-4422(09)70043-2.CrossRefPubMed
37.
De Keyser J, Steen C, Mostert JP, Koch MW: Hypoperfusion of the cerebral white matter in multiple sclerosis: possible mechanisms and pathophysiological significance. J Cereb Blood Flow Metab. 2008, 28 (10): 1645-1651. 10.1038/jcbfm.2008.72.CrossRefPubMed
38.
Varga AW, Johnson G, Babb JS, Herbert J, Grossman RI, Inglese M: White matter hemodynamic abnormalities precede sub-cortical gray matter changes in multiple sclerosis. J Neurol Sci. 2009, 282 (1-2): 28-33. 10.1016/j.jns.2008.12.036.CrossRefPubMedPubMedCentral
39.
Adhya S, Johnson G, Herbert J, Jaggi H, Babb JS, Grossman RI, Inglese M: Pattern of hemodynamic impairment in multiple sclerosis: Dynamic susceptibility contrast perfusion MR imaging at 3.0 T. Neuroimage. 2006, 33 (4): 1029-1035. 10.1016/j.neuroimage.2006.08.008.CrossRefPubMedPubMedCentral
40.
Ge Y, Law M, Johnson G, Herbert J, Babb JS, Mannon LJ, Grossman RI: Dynamic susceptibility contrast perfusion MR imaging of multiple sclerosis lesions: characterizing hemodynamic impairment and inflammatory activity. AJNR Am J Neuroradiol. 2005, 26 (6): 1539-1547.PubMed
41.
Inglese M, Adhya S, Johnson G, Babb JS, Miles L, Jaggi H, Herbert J, Grossman RI: Perfusion magnetic resonance imaging correlates of neuropsychological impairment in multiple sclerosis. J Cereb Blood Flow Metab. 2008, 28 (1): 164-171. 10.1038/sj.jcbfm.9600504.CrossRefPubMed
42.
Law M, Saindane AM, Ge Y, Babb JS, Johnson G, Mannon LJ, Herbert J, Grossman RI: Microvascular abnormality in relapsing-remitting multiple sclerosis: perfusion MR imaging findings in normal-appearing white matter. Radiology. 2004, 231 (3): 645-652. 10.1148/radiol.2313030996.CrossRefPubMed
43.
Wuerfel J, Paul F, Zipp F: Cerebral blood perfusion changes in multiple sclerosis. J Neurol Sci. 2007, 259 (1-2): 16-20. 10.1016/j.jns.2007.02.011.CrossRefPubMed
44.
Meyer-Schwickerath R, Haug C, Hacker A, Fink F, Seidel D, Hartung HP, Haupts MR: Intracranial venous pressure is normal in patients with multiple sclerosis. Mult Scler. 2011
45.
Talbert DG: Raised venous pressure as a factor in multiple sclerosis. Med Hypotheses. 2008, 70 (6): 1112-1117. 10.1016/j.mehy.2007.10.009.CrossRefPubMed
46.
Doepp F, Paul F, Valdueza JM, Schmierer K, Schreiber SJ: No cerebrocervical venous congestion in patients with multiple sclerosis. Ann Neurol. 2010, 68 (2): 173-183.PubMed
47.
Krogias C, Schroder A, Wiendl H, Hohlfeld R, Gold R: ["Chronic cerebrospinal venous insufficiency" and multiple sclerosis: critical analysis and first observation in an unselected cohort of MS patients]. Nervenarzt. 2010, 81 (6): 740-746. 10.1007/s00115-010-2972-1.CrossRefPubMed
48.
Sundstrom P, Wahlin A, Ambarki K, Birgander R, Eklund A, Malm J: Venous and cerebrospinal fluid flow in multiple sclerosis: A case-control study. Ann Neurol. 2010, 68 (2): 255-259. 10.1002/ana.22132.CrossRefPubMed
49.
Wattjes MP, van Oosten BW, de Graaf WL, Seewann A, Bot JC, van den Berg R, Uitdehaag BM, Polman CH, Barkhof F: No association of abnormal cranial venous drainage with multiple sclerosis: a magnetic resonance venography and flow-quantification study. J Neurol Neurosurg Psychiatry. 2011, 82 (4): 429-435. 10.1136/jnnp.2010.223479.CrossRefPubMed
50.
Baracchini C, Perini P, Calabrese M, Causin F, Rinaldi F, Gallo P: No evidence of chronic cerebrospinal venous insufficiency at multiple sclerosis onset. Ann Neurol. 2011, 69 (1): 90-99. 10.1002/ana.22228.CrossRefPubMed
51.
Mayer CA, Pfeilschifter W, Lorenz MW, Nedelmann M, Bechmann I, Steinmetz H, Ziemann U: The perfect crime? CCSVI not leaving a trace in MS. J Neurol Neurosurg Psychiatry. 2011, 82 (4): 436-440. 10.1136/jnnp.2010.231613.CrossRefPubMedPubMedCentral
Metadata
Title
Decreased brain venous vasculature visibility on susceptibility-weighted imaging venography in patients with multiple sclerosis is related to chronic cerebrospinal venous insufficiency
Authors
Robert Zivadinov
Guy U Poloni
Karen Marr
Claudiu V Schirda
Christopher R Magnano
Ellen Carl
Niels Bergsland
David Hojnacki
Cheryl Kennedy
Clive B Beggs
Michael G Dwyer
Bianca Weinstock-Guttman
Publication date
01-12-2011
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2011
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/1471-2377-11-128

Other articles of this Issue 1/2011

BMC Neurology 1/2011 Go to the issue

Study protocol

Risk factors and prognosis of young stroke. The FUTURE study: A prospective cohort study. Study rationale and protocol

Study protocol

Sydney epilepsy incidence study to measure illness consequences: the SESIMIC observational epilepsy study protocol

Case report

Parkinsonian phenotype in Machado-Joseph disease (MJD/SCA3): a two-case report

Research article

Metabolic changes in concussed American football players during the acute and chronic post-injury phases

Research article

Stroke awareness decreases prehospital delay after acute ischemic stroke in korea

Research article

Effectiveness and costs of phototest in dementia and cognitive impairment screening